Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:177-178 (21 January), doi:10.1136/bmj.332.7534.177-a
| The first 150 words of the full text of this article appear below. |
EditorDoshi implies that the use of statistical models to estimate flu related mortality is inappropriate.1 Not so. Epidemiologists rely on statistical models because the International Classification of Diseases (ICD) code for influenza (ICD9 487) severely undercounts the true number of flu related deaths. Doshi also implies that the Centers for Disease Control and Prevention (CDC) deliberately exaggerates flu mortality for the benefit of the pharmaceutical industry, while other scientists stand by, meek and mute. The BMJ's decision to publish Doshi's commentary with no counterpoint from an expert in the field served only to sow unnecessary confusion.
We need statistical models partly because flu is rarely confirmed in the laboratory and partly because flu brings about many more deaths from secondary bacterial pneumonia or exacerbations of underlying chronic diseases than from primary flu pneumonia. The classic Serfling modelling approach measures the total seasonal number of flu related deaths as the
Lone Simonsen, senior epidemiologist
National Institutes of Health, Bethesda, MD 20892, USA LSimonsen@niaid.nih.gov
Robert Taylor, contract analyst, Cecile Viboud, visiting fellow, Jonathan Dushoff, research scientist, Mark Miller, director, Division of Epidemiology and International Population Studies
National Institutes of Health, Bethesda, MD 20892, USA